Oligometastatic Bladder Cancer: Current Definitions, Diagnostic Challenges, and Evolving Therapeutic Strategies

Area of Science:

• Urology
• Oncology
• Medical Imaging

Background:

• Oligometastatic bladder cancer (OMBC) represents an intermediate stage between localized and widespread metastatic disease.
• Patients with OMBC generally have a better prognosis than those with metastatic bladder cancer.
• Current definitions, diagnostic criteria, and management strategies for OMBC are not standardized.

Purpose of the Study:

• To review current evidence on definitions, diagnostic approaches, and treatment strategies for OMBC.
• To highlight emerging biological and molecular insights for refining OMBC classification and therapy.
• To identify gaps in knowledge and suggest future research directions.

Main Methods:

• This study is a narrative review of existing literature on OMBC.
• It synthesizes information on diagnostic imaging, molecular markers, and therapeutic interventions.
• Emphasis is placed on recent advancements and their implications for OMBC management.

Main Results:

• Current OMBC definitions based on lesion count and distribution overlook crucial heterogeneity.
• Advanced imaging (PET/CT, MRI) and liquid biopsies show promise for detecting small-volume and micrometastatic disease.
• Therapeutic strategies like metastasis-directed and consolidative therapies are under investigation, but evidence is limited.

Conclusions:

• Prospective, biomarker-integrated, and randomized trials are crucial for OMBC.
• These trials will help refine OMBC definitions and optimize patient selection for therapy.
• The role of precision-based multimodal therapy in OMBC requires further definition.